The extracorporeal membrane oxygenation (ECMO) machine market is projected to grow from USD 961.2 million in 2024 to USD 1,676.4 million by 2032, registering a CAGR of 7.2% during the forecast period.
The extracorporeal membrane oxygenation (ECMO) machine market is driven by rising incidences of severe respiratory and cardiac failure, increasing adoption in neonatal and pediatric care, and growing demand for advanced life support technologies in critical care settings. Expanding awareness among healthcare providers about ECMO’s clinical benefits, coupled with technological advancements such as portable and user-friendly systems, is enhancing adoption rates. Trends include integration of artificial intelligence for real-time monitoring, development of compact and cost-efficient devices, and expanding applications beyond traditional use cases, particularly in managing complications from severe infections and post-surgical recovery, thereby strengthening market growth potential globally.
The extracorporeal membrane oxygenation machine market spans North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with North America leading due to advanced healthcare infrastructure and high adoption rates. Europe follows with strong clinical standards and technological expertise, while Asia-Pacific shows rapid growth from expanding healthcare capacity. Latin America sees rising adoption in specialized urban centers, and the Middle East & Africa benefit from increasing investments in critical care. Key players include Origin Biomedical, Abiomed, Eurosets S.R.L., Terumo Cardiovascular Systems, Medtronic, Fresenius, Maquet, Nipro, Livanova, Microport, Getinge, and Cytosorbents.
Market Insights
The extracorporeal membrane oxygenation (ECMO) machine market is projected to grow from USD 961.2 million in 2024 to USD 1,676.4 million by 2032, at a CAGR of 7.2%.
Rising incidences of severe respiratory and cardiac failure, along with greater use in neonatal and pediatric care, are driving demand for ECMO systems.
Technological advancements, including portable designs, AI-enabled monitoring, and improved oxygenators, are enhancing efficiency, safety, and adoption rates.
Broader clinical applications now include treatment of severe viral infections, post-transplant recovery, and high-risk surgical support.
High equipment and operational costs, along with the need for specialized infrastructure and trained personnel, remain major challenges.
North America leads with 41% share, followed by Europe (28%), Asia-Pacific (22%), Latin America (5%), and Middle East & Africa (4%).
Key players include Origin Biomedical, Abiomed, Eurosets S.R.L., Terumo Cardiovascular Systems, Medtronic, Fresenius, Maquet, Nipro, Livanova, Microport, Getinge, and Cytosorbents.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Rising Prevalence of Severe Respiratory and Cardiac Disorders
The extracorporeal membrane oxygenation (ECMO) machine market benefits from the increasing number of patients suffering from acute respiratory distress syndrome, cardiogenic shock, and other life-threatening conditions. It supports critical care when conventional treatments fail. Growing global incidences of chronic obstructive pulmonary disease and heart failure drive the need for advanced life support. Hospitals invest in ECMO to improve survival rates. Broader clinical acceptance strengthens its demand across developed and emerging healthcare systems.
For instance, In July 2022, Inspira Technologies introduced the “Liby” System, an advanced life support ECMO system designed to treat patients with life-threatening heart and lung failure, marking a significant innovation in the market.
Technological Advancements Enhancing Efficiency and Safety
The extracorporeal membrane oxygenation machine market experiences significant momentum from innovations in device design and monitoring systems. It now includes portable, compact units suited for emergency and transport scenarios. Improved membrane oxygenators, user-friendly interfaces, and automated control systems increase operational safety. Integration of real-time data analytics enables better patient management. Manufacturers focus on lowering complication risks while extending run times, meeting the demands of both specialized and general critical care units.
For instance, Medtronic introduced the VitalFlow™ ECMO system in 2024, a configurable, user-friendly solution designed for both bedside and intra-hospital transport use. This system features an intuitive touchscreen interface and incorporates Medtronic’s proven Nautilus™ ECMO oxygenator for reliable performance.
Expanding Applications Beyond Traditional Critical Care
The extracorporeal membrane oxygenation machine market sees growth from its adoption in broader clinical settings beyond traditional neonatal and cardiothoracic surgery care. It finds use in managing severe viral infections, including influenza and COVID-19 complications. Physicians deploy ECMO during high-risk surgical procedures to stabilize patients. Recovery protocols increasingly integrate ECMO support for post-transplant patients. Diverse applications help medical centers justify investments, promoting sustained equipment procurement across global healthcare networks.
Growing Investments in Healthcare Infrastructure and Training
The extracorporeal membrane oxygenation machine market benefits from increased spending on critical care infrastructure worldwide. It requires trained personnel to ensure safe and effective operation. Government funding and hospital partnerships support specialized ECMO training programs. Expanding healthcare budgets in emerging economies allow tertiary care hospitals to procure advanced systems. The rise in accredited ECMO centers improves patient access. Strong institutional support accelerates adoption across regions with improving healthcare delivery capacity.
Market Trends
Integration of Advanced Monitoring and Artificial Intelligence
The extracorporeal membrane oxygenation machine market is witnessing strong adoption of advanced monitoring technologies and artificial intelligence (AI) to enhance patient safety and treatment precision. It incorporates AI-driven analytics for real-time assessment of oxygenation levels, hemodynamics, and membrane efficiency. Predictive algorithms assist clinicians in anticipating complications, optimizing intervention timing, and improving overall outcomes. Integration with hospital information systems ensures data accessibility for remote consultations. This digital transformation is driving operational efficiency and elevating standards in ECMO-supported critical care.
For instance, the ECMO Predictive Algorithm (ECMO PAL), developed using deep neural networks and trained on over 18,000 international patient records, offers highly accurate survival predictions, outperforming traditional prognostic scores and aiding physicians in treatment decisions.
Development of Portable and Transport-Friendly Systems
The extracorporeal membrane oxygenation machine market benefits from the introduction of compact and mobile units designed for inter-hospital and intra-hospital patient transfers. It allows critical care teams to initiate ECMO support in emergency scenarios without delay. Lighter components, integrated batteries, and improved ergonomics enable safer mobility. These systems support rapid deployment in ambulances and air transport. Manufacturers focus on durability and intuitive controls to ensure consistent performance under variable environmental conditions, expanding accessibility for time-sensitive interventions.
For instance, Fresenius Medical Care received US FDA clearance in 2020 for its Novalung system, which offers enhanced mobility for acute respiratory and cardiopulmonary failure cases.
Broadened Clinical Applications in Emerging Treatment Protocols
The extracorporeal membrane oxygenation machine market is expanding beyond conventional use in neonatal and cardiac surgery units into new treatment domains. It now plays a critical role in supporting patients with severe sepsis, multi-organ failure, and post-transplant recovery. ECMO is being incorporated into advanced surgical programs to minimize intraoperative risks. High-profile research studies demonstrate its effectiveness in reducing mortality rates for severe viral respiratory infections. Broader clinical indications are reinforcing the value proposition for healthcare providers worldwide.
Growing Focus on Cost Optimization and Operational Efficiency
The extracorporeal membrane oxygenation machine market is shaped by efforts to balance advanced capabilities with cost-effective operation. It encourages the development of reusable components, longer-lasting membranes, and simplified circuit designs to reduce consumable expenses. Hospitals are adopting centralized ECMO programs to maximize utilization across multiple departments. Standardized training modules improve operational consistency, minimizing downtime and errors. Collaborative purchasing agreements and vendor partnerships further reduce capital expenditure, enabling broader adoption in both public and private healthcare sectors.
Market Challenges Analysis
High Operational Costs and Resource Requirements
The extracorporeal membrane oxygenation machine market faces constraints due to the high costs associated with equipment acquisition, consumables, and maintenance. It demands specialized facilities and advanced infrastructure, limiting adoption in resource-constrained healthcare settings. Consumable parts, such as oxygenators and tubing, require regular replacement, increasing operational expenses. Staffing ECMO programs with trained specialists adds to the financial burden. Limited reimbursement policies in some regions further hinder accessibility. These financial and logistical barriers restrict widespread deployment, particularly in smaller hospitals.
Complexity of Operation and Associated Clinical Risks
The extracorporeal membrane oxygenation machine market is challenged by the complexity of operating and managing ECMO systems, which require continuous monitoring and rapid intervention in emergencies. It carries inherent risks, including bleeding, infection, and thromboembolic events, demanding high levels of expertise. Limited availability of skilled ECMO specialists affects timely initiation of therapy in critical cases. Variations in protocols across institutions can impact treatment outcomes. Ensuring consistent training, standardization, and risk mitigation remains essential for expanding safe and effective use.
Market Opportunities
Expanding Use in Emerging Healthcare Markets
The extracorporeal membrane oxygenation machine market has significant potential in emerging economies with rapidly developing healthcare infrastructure. It benefits from government investments in tertiary care facilities and increased focus on advanced critical care capabilities. Rising awareness of ECMO’s role in improving survival rates encourages adoption in high-acuity centers. Public-private partnerships are supporting equipment procurement and training programs. Growing access to specialized care in urban hospitals creates new revenue streams for manufacturers, strengthening the market’s geographic reach.
Technological Innovation and Diversified Applications
The extracorporeal membrane oxygenation machine market is poised to gain from innovations that improve device efficiency, portability, and safety. It stands to benefit from advancements such as compact designs for emergency use, AI-enabled monitoring systems, and cost-reducing circuit components. Expanding clinical applications in trauma, transplant, and infectious disease management open new growth avenues. Collaboration between device manufacturers and research institutions fosters the development of tailored ECMO solutions. These innovations broaden adoption across both established and new medical specialties.
Market Segmentation Analysis:
By Component
The extracorporeal membrane oxygenation machine market is segmented into pumps, oxygenators, controllers, cannula, and accessories. Pumps hold a critical role in ensuring consistent blood flow, while oxygenators remain essential for efficient gas exchange. Controllers enable precise monitoring and adjustments, supporting safe operation. Cannula quality directly impacts patient outcomes, driving innovation in biocompatible materials. Accessories, including tubing and connectors, enhance system integration. Demand for advanced, durable components grows with increasing adoption in high-acuity care.
For instance, Getinge Group Japan launched the HLS SET Advanced membrane oxygenator approved for up to two weeks of use, representing a major step forward for long-term ECMO support in severe cases.
By Services
The extracorporeal membrane oxygenation machine market is categorized into veno-venous, veno-arterial, and arterio-venous services. Veno-venous ECMO dominates for severe respiratory failure cases, offering targeted lung support. Veno-arterial ECMO addresses both cardiac and respiratory complications, making it vital in critical emergencies. Arterio-venous ECMO sees specialized use in renal support and certain perfusion therapies. Service selection depends on patient condition, procedural complexity, and institutional expertise. Hospitals invest in multi-service capabilities to handle diverse clinical requirements.
For instance, Medtronic provides ECMO equipment such as the Affinity® and Minimax® oxygenation systems, which are used for both veno-venous and veno-arterial ECMO services. Their systems support patients with severe cardiac and respiratory conditions in critical care settings.
By Patient Type
The extracorporeal membrane oxygenation machine market serves neonates, pediatric, and adult patients. It plays a pivotal role in neonatal care, addressing congenital heart and lung disorders. Pediatric cases benefit from tailored flow control and advanced monitoring systems. Adult applications are expanding due to rising incidences of acute respiratory distress syndrome and cardiac arrest. Each patient type demands specific cannulation strategies and equipment configurations. Customized solutions ensure optimal support across varying physiological needs.
Segments:
Based on Component:
Pumps
Oxygenator
Controllers
Cannula
Accessories
Based on Services:
Veno-Venous
Veno-Arterial
Arterio-Venous
Based on Patient Type:
Neonates
Pediatric
Adult
Based on Application:
Respiratory
Neonates
Pediatric
Adult
Cardiac
Neonates
Pediatric
Adult
ECPR
Neonates
Pediatric
Adult
Based on the Geography:
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Regional Analysis
North America
North America holds 41% share of the extracorporeal membrane oxygenation machine market, driven by advanced healthcare infrastructure and strong adoption in critical care units. It benefits from a high concentration of ECMO-trained specialists and leading medical research institutions. Hospitals integrate ECMO in cardiac, respiratory, and transplant care programs. The presence of major manufacturers supports continuous technology upgrades. Increasing prevalence of chronic heart and lung diseases sustains demand. Government funding for specialized care centers reinforces market leadership in the region.
Europe
Europe accounts for 28% share of the extracorporeal membrane oxygenation machine market, supported by robust public healthcare systems and strict clinical standards. It emphasizes ECMO deployment in both adult and pediatric intensive care units. Growing use in advanced surgical and post-operative recovery programs strengthens regional demand. Cross-border collaborations among EU healthcare networks enhance training and resource allocation. Rising cases of severe respiratory illnesses contribute to higher utilization rates. Technological advancements from European manufacturers drive further adoption.
Asia-Pacific
Asia-Pacific represents 22% share of the extracorporeal membrane oxygenation machine market, with growth fueled by expanding healthcare infrastructure and rising investments in tertiary care facilities. It experiences increased adoption in urban hospitals addressing high patient volumes. Rapid growth in medical tourism, particularly in cardiac and transplant surgeries, supports demand. Governments implement training initiatives to expand ECMO expertise. Rising awareness of ECMO’s role in improving survival rates accelerates equipment procurement. Local manufacturing capabilities are strengthening the regional supply chain.
Latin America
Latin America holds 5% share of the extracorporeal membrane oxygenation machine market, with demand concentrated in specialized hospitals in Brazil, Mexico, and Argentina. It faces challenges from limited infrastructure in rural areas, yet urban medical centers invest in advanced ECMO units. Training partnerships with global healthcare organizations expand operational capacity. The region sees rising adoption for pediatric and neonatal care. Growing private healthcare investments and government support for high-acuity care create new opportunities for expansion.
Middle East & Africa
The Middle East & Africa account for 4% share of the extracorporeal membrane oxygenation machine market, led by the Gulf Cooperation Council countries. It benefits from large-scale investments in critical care and transplant centers. Wealthier nations import advanced ECMO technologies to meet rising demand in complex cardiac cases. Regional healthcare reforms aim to improve access to life-saving equipment. Strategic collaborations with international suppliers ensure technology transfer. Expansion of specialized training programs supports long-term market development.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The extracorporeal membrane oxygenation machine market is characterized by strong competition among global and regional players focusing on technological innovation, product reliability, and expanded clinical applications. It includes leading companies such as Origin Biomedical, Abiomed, Eurosets S.R.L., Terumo Cardiovascular Systems Corporation, Medtronic, Fresenius Medical Care A.G. & Co. KGAA, Maquet Holding, Nipro Corporation, Livanova plc, Microport, Getinge Group, and Cytosorbents Corporation. These manufacturers invest in R&D to develop compact, portable systems, improve oxygenator efficiency, and integrate advanced monitoring capabilities. Strategic partnerships with healthcare providers and training institutions strengthen their market position, while product approvals and regulatory compliance enhance credibility. Many players expand their presence in emerging markets through localized manufacturing and distribution networks, enabling faster delivery and competitive pricing. The market also sees growing collaboration between device makers and research centers to explore new ECMO applications in infectious diseases, transplant care, and advanced surgical procedures. Intensifying competition drives continuous innovation, broader service portfolios, and enhanced after-sales support to meet the evolving needs of high-acuity care environments worldwide.
Recent Developments
In July 2023, BreathMo, an advanced ECMO system featuring maglev technology, was launched at the ASAIO Conference, highlighting China’s innovation in addressing local critical care needs.
In April 2023, Abbott obtained two new U.S. FDA clearances for its CentriMag Blood Pump, expanding its indication for extended use in adults requiring ECMO support for severe heart and lung conditions.
In January 2025, CBM Lifemotion® achieved MDR CE Mark approval for its Lifemotion® ECMO System, allowing commercial rollout of its transport-optimized device in Europe.
In April 2025, Eurosets unveiled the Xtreme Rescue portable ECMO unit and Landing Breathe capnometer at EuroELSO in Milan.
Market Concentration & Characteristics
The extracorporeal membrane oxygenation machine market demonstrates moderate to high concentration, with a limited number of established players dominating global supply. It is characterized by high entry barriers due to stringent regulatory requirements, complex manufacturing processes, and the need for specialized clinical training for end users. Leading companies compete through technological innovation, focusing on portable designs, enhanced oxygenator performance, and AI-enabled monitoring systems. It favors players with strong R&D capabilities, global distribution networks, and established relationships with tertiary care hospitals. The market is driven by critical care demand in high-acuity settings, encouraging ongoing investment in product reliability, safety, and ease of use. Strategic partnerships, mergers, and acquisitions are common to expand product portfolios and geographic presence. It also exhibits growing demand from emerging economies, where improving healthcare infrastructure and government investments in advanced life support create opportunities for established manufacturers to strengthen their global footprint
Report Coverage
The research report offers an in-depth analysis based on Component, Services, Patient Type, Application and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Demand for ECMO systems will increase with the rising burden of severe respiratory and cardiac conditions worldwide.
Technological innovation will focus on compact, portable devices to support emergency and transport applications.
AI-based monitoring solutions will gain wider adoption to enhance treatment precision and patient safety.
ECMO usage will expand into new clinical areas, including trauma care and complex surgical procedures.
Emerging economies will become key growth markets due to healthcare infrastructure development.
Training programs will expand to address the shortage of skilled ECMO specialists.
Hospitals will invest in multi-service ECMO capabilities to manage diverse patient needs.
Partnerships between manufacturers and healthcare providers will accelerate technology adoption.
Reusable components and cost-efficient designs will help reduce operational expenses for healthcare facilities.
Regulatory harmonization across regions will improve market accessibility and product standardization.
For Table OF Content – Request For Sample Report –
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Request Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Frequently Asked Questions
What is the current market size for extracorporeal membrane oxygenation machine market, and what is its projected size in 2032?
The market size reached USD 961.2 million in 2024 and is projected to reach USD 1,676.4 million by 2032, reflecting strong global demand growth.
Which extracorporeal membrane oxygenation machine market segment held the largest share in 2024?
In 2024, the veno-venous ECMO segment held the largest market share, primarily due to its widespread use in managing severe respiratory failure cases globally.
Who are the leading companies in the extracorporeal membrane oxygenation machine market?
Leading players include Origin Biomedical, Abiomed, Eurosets S.R.L., Terumo Cardiovascular Systems, Medtronic, Fresenius, Maquet, Nipro, Livanova, Microport, Getinge, and Cytosorbents Corporation.
Which region commanded the largest share of the extracorporeal membrane oxygenation machine market in 2024?
North America held the largest share in 2024 at 41%, supported by advanced healthcare infrastructure, high adoption rates, and strong presence of key ECMO manufacturers.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The global extracorporeal shockwave therapy (ESWT) devices market is anticipated to grow at a substantial CAGR of 5.5% in the upcoming years. The global extracorporeal shockwave therapy (ESWT) devices industry is estimated to be worth USD 104.6 million in 2021 and is expected to be worth USD 144.22 million by 2028.
The market for circulatory support devices is projected to grow significantly, expanding from USD 5,395 million in 2024 to USD 9,269.614 million by 2032, representing a compound annual growth rate (CAGR) of 7%.
The Endoscopy Sterilization Market size was valued at USD 1289.3 million in 2024 and is anticipated to reach USD 2404.1 million by 2032, at a CAGR of 8.1% during the forecast period.
The MEMS in medical applications market is projected to grow from USD 1,101.7 million in 2024 to USD 1,935.8 million by 2032, registering a CAGR of 7.3% during the forecast period.
The epoxy active diluent market is projected to grow from USD 918.9 million in 2024 to USD 1,128.4 million by 2032, registering a CAGR of 2.6% during the forecast period.
External Defibrillators Market size was valued at USD 4198.5 million in 2024 and is anticipated to reach USD 8805.4 million by 2032, at a CAGR of 9.7% during the forecast period.
The e pharmacy market size was valued at USD 121557.5 million in 2024 and is anticipated to reach USD 320645.8 million by 2032, at a CAGR of 12.89 % during the forecast period (2024-2032).
The Endometrial Cancer Treatment Market size was valued at USD 30,681.7 million in 2024 and is anticipated to reach USD 48,901.9 million by 2032, growing at a compound annual growth rate (CAGR) of 6% during the forecast period.
Endotherapy Devices Market size was valued at USD 4690.5 million in 2024 and is anticipated to reach USD 7419.7 million by 2032, at a CAGR of 5.9% during the forecast period.
The ketamine treatment market is projected to grow from USD 1,280.3 million in 2024 to USD 3,526 million by 2032, registering a CAGR of 13.5% during the forecast period.
The biopharmaceutical logistics market size was valued at USD 145692.7 million in 2024 and is anticipated to reach USD 254854.5 million by 2032, at a CAGR of 7.24 % during the forecast period (2024-2032).
The Collateral Ligament Stabilizer System market was valued at USD 2,242.5 million in 2024 and is projected to reach USD 3,631.2 million by 2032, growing at a compound annual growth rate (CAGR) of 6.21% during the forecast period.
The End Stage Renal Disease (ESRD) market was valued at approximately USD 111,460.5 million in 2024. It is projected to grow significantly, reaching around USD 302,023.12 million by 2032, reflecting a compound annual growth rate (CAGR) of 13.27% over the forecast period.
Cloud Orchestration Market size was valued at USD 5,429.62 million in 2018 to USD 11,764.67 million in 2024 and is anticipated to reach USD 49,664.69 million by 2032, at a CAGR of 18.39% during the forecast period.
Purchase Options
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.
